drug discovery

News

AZ's Alexion inks wide-ranging AI agreement with Verge

AstraZeneca has made a sizeable play in applying artificial intelligence to drug discovery in its rare disease unit Alexion, partnering with Verge Genomics in a deal that

News

AI specialist Intelligent Omics bags J&J deal

UK artificial intelligence (AI) specialist Intelligent Omics has entered into a research collaboration with Johnson & Johnson, within weeks of joining the big pharma's

News

Genesis raises $200m for AI drug discovery engine

Investor interest in artificial intelligence-powered drug discovery shows little signs of wearing off, as start-up Genesis Therapeutics rakes in an impressive $200 million

News

Paul Biondi of Flagship's Pioneering Medicines

Pfizer inks $7bn strategic level R&D deal with Flagship

Pfizer has just made venture capital firm Flagship Pioneering a key component of its R&D engine, signing a deal worth up to $7 billion that will allow it to harvest ne

News

AI model predicts risk of birth defects from new drugs

Researchers in the US have developed an artificial intelligence (AI) algorithm that can be used to predict whether a drug has the potential to harm developing foetuses in

News

Consortium hunts new KRAS drugs with fruit flies and AI

The launch of the first drugs to inhibit the cancer-related protein KRAS was a milestone moment in oncology, but their efficacy wanes over time and tumours can develop res

AZ's Alexion inks wide-ranging AI agreement with Verge

AI specialist Intelligent Omics bags J&J deal

Genesis raises $200m for AI drug discovery engine

Pfizer inks $7bn strategic level R&D deal with Flagship

AI model predicts risk of birth defects from new drugs

Consortium hunts new KRAS drugs with fruit flies and AI

LSX2026: On a therapeutic vision for ocular disease, with Al...

Using AI-driven synthetic personas to take your insights fur...

drug discovery

Editor's Picks